drugset / Trial / NCT05352191
Beclomethasone in Healthy Athletes
Phase 4
Unknown
30 enrolled
Western Norway University of Applied Sciences
The Norwegian Doping Control Laboratory · collabThe Norwegian School of Sport Sciences · collab
RandomizedParallel-groupQuadruple-blindOther
Summary
The present study aims to assess her urine concentration of beclomethasone during and after one week of use according to the World Antidoping agency's regulations. The study will assess utility of dried blood spots to detect use of beclomethasone and the effect approved use of beclomethasone has on endurance performance in healthy (non-asthmatic ) athletes.
Timeline
- Start
- 2022-09-01
- Primary completion
- 2023-01-01
- Completion
- 2024-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Beclomethasone | Small molecule | 800 ug | — |
Indications
No indication recorded.